PharmacoEconomics

, Volume 2, Issue 6, pp 449–455 | Cite as

Overview of International Pharmacy Pricing

  • Albert I. Wertheimer
  • Sondra K. Grumer
Leading Article

Keywords

Drug Price Transfer Price Price Decision Pharmaceutical Price Pharmaceutical Prex 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anon. Generic Drug Sales Boom. American Druggist 201-202: 17, October 1990Google Scholar
  2. Anon. Thumbs down for commission action on pricing. Scrip 1629: 4–7, June 28, 1991aGoogle Scholar
  3. Anon. Disharmony over EC pricing and reimbursement. Scrip Magazine 20-22, May 1992Google Scholar
  4. Anon. 1990 rise in prescription drug prices averages nearly 8%. American Journal of Hospital Pharmacy 48: 1122, June 1991bGoogle Scholar
  5. Anon. EC pharma price update. Scrip No. 1677: 4, December 13, 1991cGoogle Scholar
  6. Bligh J, Walley T. The UK indicative prescribing scheme: background and operation. PharmacoEconomics 2: 137–152, 1992PubMedCrossRefGoogle Scholar
  7. Escovitz A, Pathak DS (Ed.) Understanding the labyrinth of pharmaceutical pricing. Journal of Research in Pharmaceutical Economics 3: 3–6, 1991Google Scholar
  8. Henry D. Economic analysis as an aid to subsidisation: the development of Australian guidelines for Pharmaceuticals. PharmacoEconomics 1: 54–67, 1992PubMedCrossRefGoogle Scholar
  9. Institute for Pharmaceutical Economics. Government influence in Pharmaceutical pricing: lessons from home and abroad. Institute for Pharmaceutical Economics, Philadelphia, 1991.Google Scholar
  10. Levy R. Prescription cost sharing: economic and health impacts, and implications for health policy. PharmacoEconomics 2: 219–237, 1992PubMedCrossRefGoogle Scholar
  11. Nowotny, OH. International drug prices, reasonable or exorbitant? Roche, Basel, 1971.Google Scholar
  12. Plagakis J. Of prices and cows. Drug Topics January 6: 21, 1992Google Scholar
  13. Smythe SM. Prescription pricing: A GAO evaluation. Journal of Research in Pharmaceutical Economics 3(1): 55–64, 1991Google Scholar
  14. Spilker B. Multinational drug companies, Raven Press, NY, 1989Google Scholar
  15. Spivey RN, Wertheimer AI, Rucker TD, (Eds) International pharmaceutical services, Haworth Press, New York, 1992Google Scholar
  16. Teske R. Pharmaceutical pricing within a health care system in crisis. Journal of Research in Pharmaceutical Economics 1: 27–36, 1991Google Scholar
  17. Tucker D. The world health market, Euromonitor Publication Limited, England, 1984Google Scholar
  18. Zellmer WA. Candor on the pricing of Pharmaceuticals. American Journal of Hospital Pharmacy 47: 2469, 1990PubMedGoogle Scholar

Copyright information

© Adis International Limited 1992

Authors and Affiliations

  • Albert I. Wertheimer
    • 1
  • Sondra K. Grumer
    • 1
  1. 1.Philadelphia College of Pharmacy and SciencePhiladelphiaUSA

Personalised recommendations